| TIME | ARTICLE |
JOURNAL |
IF | PUBMED ID | PRODUCT |
|---|---|---|---|---|---|
| 2022 | Lactoferrin attenuated urban particulate matter-induced nephrotoxicity by regulating the CSF2/CENPE axis | Environmental Pollution | 9.988 | 36528199 | |
| 2022 | Boosting the detection performance of severe acute respiratory syndrome coronavirus 2 test through a sensitive optical biosensor with new superior antibody | Bioengineering Translational Medicine | 10.684 | 36248235 | |
| 2022 | Suramin enhances chondrogenic properties by regulating the p67phox/PI3K/AKT/SOX9 signalling pathway | Bone Joint Res. | 5.853 | 36222195 | |
| 2022 | MiR-29a inhibits MPP + - Induced cell death and inflammation in Parkinson's disease model in vitro by potential targeting of MAVS | European Journal of Pharmacology | 5.195 | 36174668 | |
| 2022 | WWOX-rs13338697 genotype predicts therapeutic efficacy of ADI-PEG 20 for patients with advanced hepatocellular carcinoma | Frontiers in Oncology | 5.738 | 36530994 | |
| 2022 | A missense variant in the nuclear localization signal of DKC1 causes Hoyeraal-Hreidarsson syndrome | npj Genomic Medicine | 7.227 | 36309505 | |
| 2022 | MEX3A mediates p53 degradation to suppress ferroptosis and facilitate ovarian cancer tumorigenesis | Cancer Research | 13.678 | 36354374 | |
| 2022 | The multi-targeted tyrosine kinase inhibitor SKLB610 resensitizes ABCG2-overexpressing multidrug-resistant cancer cells to chemotherapeutic drugs | Biomedicine & Pharmacotherapy | 7.419 | 36068781 | |
| 2022 | P-glycoprotein Mediates Resistance to the Anaplastic Lymphoma Kinase Inhiitor Ensartinib in Cancer Cells | cancers | 6.575 | 35565470 |
